We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUFF
1376
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$2.85M 0.01%
100,420
-4,601
-4% -$113K
CLF icon
1377
Cleveland-Cliffs
CLF
$6.58B
$2.85M 0.01%
398,109
-706
-0.2% -$5.27K
ATRI
1378
DELISTED
Atrion Corp
ATRI
$2.84M 0.01%
4,232
-112
-3% -$71.9K
TIME
1379
DELISTED
Time Inc.
TIME
$2.84M 0.01%
210,184
+3,320
+2% +$44.6K
CALY
1380
Callaway Golf Company
CALY
$3.34B
$2.83M 0.01%
196,354
+2,455
+1% +$32.5K
SYNA icon
1381
Synaptics
SYNA
$4.29B
$2.83M 0.01%
72,152
-482
-0.7% -$21.7K
ESRT icon
1382
Empire State Realty Trust
ESRT
$862M
$2.83M 0.01%
137,602
-1,423
-1% -$29.1K
CNDT icon
1383
Conduent
CNDT
$244M
$2.82M 0.01%
180,132
+1,030
+0.6% +$16.8K
PRAA icon
1384
PRA Group
PRAA
$656M
$2.82M 0.01%
98,486
+820
+0.8% +$27.4K
OCLR
1385
DELISTED
Oclaro Inc.
OCLR
$2.82M 0.01%
326,994
+38,758
+13% +$349K
DGI
1386
DELISTED
DigitalGlobe Inc.
DGI
$2.82M 0.01%
80,032
-41
-0.1% -$1.4K
MXL icon
1387
MaxLinear
MXL
$6.24B
$2.82M 0.01%
118,673
+9,373
+9% +$225K
MDC
1388
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.82M 0.01%
106,866
+1,742
+2% +$46K
HZNP
1389
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.81M 0.01%
221,853
+11,010
+5% +$140K
AZZ icon
1390
AZZ Inc
AZZ
$4.38B
$2.81M 0.01%
57,718
+1,045
+2% +$52K
SPB icon
1391
Spectrum Brands
SPB
$2.05B
$2.81M 0.01%
26,543
-1,265
-5% -$142K
APOG icon
1392
Apogee Enterprises
APOG
$827M
$2.8M 0.01%
58,092
+1,005
+2% +$49.4K
CAL icon
1393
Caleres
CAL
$433M
$2.8M 0.01%
91,844
+1,475
+2% +$39.9K
W icon
1394
Wayfair
W
$11.5B
$2.79M 0.01%
41,407
-1,595
-4% -$118K
NAV
1395
DELISTED
Navistar International
NAV
$2.79M 0.01%
63,298
-130
-0.2% -$4.31K
IPCC
1396
DELISTED
Infinity Property & Casualty C
IPCC
$2.79M 0.01%
29,605
+967
+3% +$89.8K
AF
1397
DELISTED
Astoria Financial Corporation
AF
$2.79M 0.01%
129,707
-71,727
-36% -$1.43M
THRM icon
1398
Gentherm
THRM
$1.25B
$2.78M 0.01%
74,902
+1,760
+2% +$60.2K
MNTA
1399
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.78M 0.01%
150,340
+10,125
+7% +$169K
GCP
1400
DELISTED
GCP Applied Technologies Inc.
GCP
$2.77M 0.01%
90,129
+515
+0.6% +$15.4K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.